Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Frequency of adverse events due to photodynamic therapy called into question

May 23, 2000

Vaccination with TAP1 gene promotes immune response to small cell lung cancer

May 23, 2000

Oxigene and Techniclone sign joint venture for vascular targeting therapies

May 23, 2000

NuChem selects NC-381 as lead anticancer agent

May 22, 2000

Antisense modulation of TRAF expression by new Isis compounds

May 22, 2000

PDL and Toagosei collaborate on SMART anti-VEGF development

May 22, 2000

Antisense oligonucleotides for modifying bcl-x expression in the Isis pipeline

May 19, 2000

SuperGen anticancer compound subject of new CRADA

May 19, 2000

New inhibitor of ICAM-1/LFA-1-mediated cell adhesion produced by Streptomyces

May 19, 2000

EntreMed responds to premature disclosure of trial data

May 19, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...